
Cancer Library VCC
@VCCLibrary
Followers
1K
Following
160
Media
36
Statuses
20K
The only cancer specialist library service in Wales. Supporting NHS and academic staff, students and health professionals throughout the Principality.
Cardiff
Joined March 2013
RT @VelindreTrust: š Weāve been shortlisted for two NHS Wales Awards!. Llongyfarchiadau to the South East Wales Immunotherapy Toxicity Servā¦.
0
2
0
RT @IOClinicalNet: Itās the hot topic in Immunotherapy right now š„. @AOlssonBrown has just been discussing the impact of managing HLH withiā¦.
0
1
0
NICE Technology Appraisal [1081] TAZanubrutinib for treating relapsed or refractory mantle cell lymphoma #Cancer.
0
0
0
Metformin for patients with metastatic #prostatecancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
0
0
0
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer #Cancer.
0
0
0
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in #prostatecancer ā a systematic review and expert consensus #Cancer.
0
0
0
Comparing adaptive and dose redistributed radiotherapy to conventional #radiotherapy in head and neck cancer ā Quality of life results from the phase III ARTFORCE trial #Cancer.
0
0
0
Breastfeeding After Hormone ReceptorāPositive #BreastCancer: Results From the POSITIVE Trial
0
0
0
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy #Cancer.
0
0
0
Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body #radiotherapy: results from a randomized pilot study #Cancer.
0
0
0
Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study #Cancer.
0
0
0
The use of radiotherapy in the cure of different cancers - further results from the FORTY (Favourable Outcomes from RadioTherapY) project #Cancer.
0
0
0
This weeks episode is out now, the final chapter in the series on HLH!! Episode 150 HLH Final Part - Management @RickyFrazer1 @AOlssonBrown @VelindreCS.
0
0
0
RT @IOClinicalNet: We are under way at @HiltonLeedsCity diving into Capacity Management in Immuno-Oncology Service Delivery. Another fantaā¦.
0
3
0
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial #Cancer.
0
0
0